Grown Rogue International (GRUSF) Revenue Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Revenue Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.84% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.19% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 15.52% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.49% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.66% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 2.94% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.41% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.17% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.85% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 164.98% |
| Apr 30, 2023 | 72.36% |
| Jan 31, 2023 | 59.99% |
| Jan 31, 2022 | 64.78% |
| Jul 31, 2021 | 64.54% |
| Apr 30, 2021 | 74.20% |
| Jan 31, 2021 | 83.20% |
| Feb 28, 2015 | 5.95% |
| Nov 30, 2014 | 1.41% |
| Aug 31, 2014 | 4.09% |
| May 31, 2014 | 15.97% |
| Feb 28, 2014 | -15.57% |
| Nov 30, 2013 | -1.47% |
| Aug 31, 2013 | -5.67% |
| May 31, 2013 | -19.08% |
| Feb 28, 2013 | -34.31% |
| Nov 30, 2012 | -25.93% |
| Aug 31, 2012 | -35.00% |
| May 31, 2012 | -21.10% |
| Feb 29, 2012 | 239.76% |